+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression

RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression

Journal of Cellular Physiology 226(9): 2360-2369

The tumor suppressor candidate gene Ras association domain family 1, isoform A (RASSF1A) encodes a microtubule-associated protein that is implicated in the regulation of cell proliferation, migration, and apoptosis. Several studies indicate that down-regulation of RASSF1A resulting from promoter hypermethylation is a frequent epigenetic abnormality in malignant melanoma. In this study, we report that compared with melanocytes in normal skins or benign skin lesions, RASSF1A is down-regulated in melanoma tissues as well as cell lines, and its expression negatively correlates with lymph node metastasis. Following ectopic expression in RASSF1A-deficient melanoma A375 cell line, RASSF1A reduces cell viability, suppresses cell-cycle progression but enhances apoptotic cell death. In vivo, RASSF1A expression inhibits the tumorigenic potential of A375 cells in nude mice, which also correlates with decreased cell proliferation and increased apoptosis. On the molecular level, ectopic RASSF1A expression leads to differential expression of 209 genes, including 26 down-regulated and 183 up-regulated ones. Among different signaling pathways, activation of the apoptosis signal-regulating kinase 1 (ASK1)/p38 MAP kinase signaling is essential for RASSF1A-induced mitochondrial apoptosis, and the inhibition of the Akt/p70S6 kinase/eIF4E signaling is also important for RASSF1A-mediated apoptosis and cell-cycle arrest. This is the first study exploring the biological functions and the underlying mechanisms of RASSF1A during melanoma development. It also identifies potential targets for further diagnosis and clinical therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333493

Download citation: RISBibTeXText

PMID: 21660959

DOI: 10.1002/jcp.22568

Related references

RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Research 65(9): 3682-3690, 2005

SNAP23 suppresses cervical cancer progression via modulating the cell cycle. Gene, 2018

Diphenylene iodonium interferes with cell cycle progression and induces apoptosis by modulating NAD(P)H oxidase/ROS/cell cycle regulatory pathways in Burkitt's lymphoma cells. Oncology Reports 33(3): 1434-1442, 2015

Dextran sulfate suppresses cell adhesion and cell cycle progression of melanoma cells. Anticancer Research 25(2a): 895-902, 2005

ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma. Oncotarget (): -, 2016

Osthole induces apoptosis, suppresses cell-cycle progression and proliferation of cancer cells. Anticancer Research 34(11): 6473-6480, 2015

Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro. Biomedicine & PharmacoTherapy 69: 402-408, 2015

Methoxy- and fluoro-chalcone derivatives arrest cell cycle progression and induce apoptosis in human melanoma cell A375. Biological & Pharmaceutical Bulletin 32(6): 1109-1113, 2009

Transfection with siRNA suppresses expression of DNA-mismatch repair enzyme hMSH2 in melanoma cell lines thereby modulating repair of UV-induced DNA-damage as well as UV- and chemotherapy-induced apoptosis and cell death. Journal of Investigative Dermatology 123(2), August, 2004

Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Research 57(24): 5521-5527, 1998

Tetramethoxychalcone, a chalcone derivative, suppresses proliferation, blocks cell cycle progression, and induces apoptosis of human ovarian cancer cells. Plos One 9(9): E106206-E106206, 2015

Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway. International Journal of Molecular Sciences 19(7), 2018

The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor. Carcinogenesis 19(10): 1743-1747, 1998

Isophilippinolide A arrests cell cycle progression and induces apoptosis for anticancer inhibitory agents in human melanoma cells. Journal of Agricultural and Food Chemistry 62(5): 1057-1065, 2014

Blocking of NF-kappa-B by dominant negative I-kappa-B-alpha mutant in the Hodgkin cell line HD-MyZ reduces cell cycle progression, promotes apoptosis and suppresses tumor growth in SCID mice. Blood 88(10 SUPPL 1 PART 1-2): 385A, 1996